Synopsis:
Advanced Enzyme Technologies and Tarsons Products came into focus following significant bulk deal activity in the previous trading session.
Stocks under consideration today are those that experienced significant bulk deal activity in the previous trading session. Such transactions, which involve large purchases or sales of shares by institutional or high-net-worth investors, frequently signal changes in market sentiment or strategic positioning.
These movements can attract trader and investor interest because they may indicate potential momentum or changes in ownership patterns that could impact the stock’s short-term performance.
The following stocks came into focus after witnessing significant bulk deal activity on August 29, 2025.
1. Advanced Enzyme Technologies Ltd
According to the latest bulk deal data on NSE, Polunin Emerging Markets Small Cap Fund LLC purchased around 12.51 lakh shares at an average price of Rs. 353.50, making a total investment of about Rs. 44.22 crore (equivalent to a 1.12 percent stake).
About the company
Advanced Enzyme Technologies Limited is an Indian company that manufactures enzymes and probiotics. The company produces and markets approximately 400 products derived from 68 indigenous enzymes and probiotics.
These products are used in industries such as human and animal nutrition, healthcare, baking, fruit and vegetable processing, brewing, grain and dairy processing, protein modification, textiles, leather, biofuels, and oils and fats.
It provides solutions for human nutrition (e.g., serratiopeptidase, fungal lactase, fungal lipase, papain), animal nutrition (DigeGrain products), food and non-food processing, and oil extraction and refining.
With a market capitalization of Rs. 3,733.47 crore, Advanced Enzyme Technologies Limited is trading at Rs. 333.50, down by 3.60 percent from its previous close of Rs. 345.95 per equity share.
2. Tarsons Products Ltd
According to the latest bulk deal data on NSE, Anantnath Skycon Private Limited purchased 7.70 lakh shares at an average price of Rs. 315, making a total investment of about Rs. 24.25 crore (equivalent to a 1.45 percent stake). In contrast, Troo Capital Ltd sold around 4.19 lakh shares worth ~Rs. 13.19 crore at an average price of Rs. 315 and Kuber India Fund sold 3.50 lakh shares worth Rs. 11.03 at an average price of Rs. 315 per share.
About the company
Tarsons Products Ltd. (TPL) is an Indian labware manufacturer involved in designing, developing, producing, and marketing consumables, reusables, and benchtop equipment for laboratories, catering to research institutions, academic bodies, pharmaceutical firms, CROs, diagnostic companies, and hospitals.
With a market capitalization of Rs. 1,707.12 crore, Tarsons Products Limited is trading at Rs. 320.85, up by 2.90 percent from its previous close of Rs. 311.80 per equity share.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 2 Stocks in focus after shares worth ₹44 Cr exchanged hands via bulk deal appeared first on Trade Brains.